Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators
(Adnkronos) – VIENNA, March 30, 2023 /PRNewswire/ — Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More
Contact:Uschi MayerExternal Communications & PRCROMA-PHARMA GmbHCromazeile 2, A-2100 Leobendorf, AustriaM.: +43 676 84 68 68 966E: [email protected]
Logo: https://mma.prnewswire.com/media/2044449/Croma_Pharma_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/croma-pharma-further-strengthening-its-portfolio-with-philart-biostimulators-301786087.html
—immediapress/[email protected] (Web Info)
Last Updated on 30 Marzo 2023 by Redazione
